'On consolidated basis
Quarter ended June 2025 compared with Quarter ended June 2024.
Net sales (including other operating income) of Torrent Pharmaceuticals has increased 11.16% to Rs 3178 crore. Operating profit margin has jumped from 31.62% to 32.47%, leading to 14.16% rise in operating profit to Rs 1,032.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 14.23% to 12.62%. Purchase of finished goods cost fell from 10.83% to 10.77%. Employee cost increased from 19.04% to 19.28%. Other expenses fell from 24.61% to 24.44%.
PBIDT rose 7.22% to Rs 995 crore. Provision for interest fell 25.33% to Rs 56 crore.
PBDT rose 10.08% to Rs 939 crore. Provision for depreciation rose 2.03% to Rs 201 crore.
Profit before tax grew 12.50% to Rs 738.00 crore. Share of profit/loss were nil in ...
Pleaselogin & subscribe to view the full report.
More Reports
|
|